应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVR Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
休市中 12-12 16:00:00 EST
4.98
-0.27
-5.14%
盘后
4.98
+0.00
0.00%
18:04 EST
最高
5.29
最低
4.90
成交量
16.92万
今开
5.25
昨收
5.25
日振幅
7.43%
总市值
2.05亿
流通市值
1.51亿
总股本
4,120万
成交额
85.39万
换手率
0.56%
流通股本
3,036万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
美股速递 · 11-27
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验
投资观察 · 11-20
安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验
Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡
美股速递 · 10-29
Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡
Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况
美股速递 · 10-28
Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况
Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告
美股速递 · 10-24
Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告
Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始
美股速递 · 10-15
Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始
Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)
美股速递 · 10-15
Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)
Anteris Technologies Global Corp.6月25日成交额为48.11万美元
市场透视 · 06-26
Anteris Technologies Global Corp.6月25日成交额为48.11万美元
Anteris Technologies Global Corp.6月18日成交额为79.95万美元
市场透视 · 06-19
Anteris Technologies Global Corp.6月18日成交额为79.95万美元
Anteris Technologies Global Corp.6月17日成交额为78.71万美元
市场透视 · 06-18
Anteris Technologies Global Corp.6月17日成交额为78.71万美元
Anteris Technologies Global Corp.6月16日成交额为107.35万美元
市场透视 · 06-17
Anteris Technologies Global Corp.6月16日成交额为107.35万美元
Anteris Technologies Global Corp.6月13日成交额为130.45万美元
市场透视 · 06-14
Anteris Technologies Global Corp.6月13日成交额为130.45万美元
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
金融界 · 01-09
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
异动解读 · 2024-12-14
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
智通财经 · 2024-12-10
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
加载更多
公司概况
公司名称:
Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。
发行价格:
--
{"stockData":{"symbol":"AVR","market":"US","secType":"STK","nameCN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","latestPrice":4.98,"timestamp":1765573200000,"preClose":5.25,"halted":0,"volume":169186,"hourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.98,"latestTime":"18:04 EST","volume":1628,"amount":8107,"timestamp":1765580665816},"delay":0,"floatShares":30362399,"shares":41197570,"eps":-2.560628,"marketStatus":"休市中","change":-0.27,"latestTime":"12-12 16:00:00 EST","open":5.25,"high":5.29,"low":4.9,"amount":853854.6722400001,"amplitude":0.074286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.560628,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1734066000000,"exchange":"NASDAQ","adjPreClose":5.25,"postHourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.98,"latestTime":"18:04 EST","volume":1628,"amount":8107,"timestamp":1765580665816},"volumeRatio":0.9751156664675377},"requestUrl":"/m/hq/s/AVR","defaultTab":"news","newsList":[{"id":"1109513896","title":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1109513896","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109513896?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:38","pubTimestamp":1764193088,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1145132209","title":"安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1145132209","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145132209?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:23","pubTimestamp":1763569381,"startTime":"0","endTime":"0","summary":"11月3日 - 安特里斯科技全球公司:*FDA批准Duravr THV全球关键试验*。进一步公司报道:AVR.O","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1160436362","title":"Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡","url":"https://stock-news.laohu8.com/highlight/detail?id=1160436362","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160436362?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:09","pubTimestamp":1761689348,"startTime":"0","endTime":"0","summary":"Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"1155538760","title":"Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1155538760","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155538760?lang=zh_cn&edition=full","pubTime":"2025-10-28 05:44","pubTimestamp":1761601486,"startTime":"0","endTime":"0","summary":"Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1199476263","title":"Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1199476263","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199476263?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:50","pubTimestamp":1761259809,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1113345988","title":"Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始","url":"https://stock-news.laohu8.com/highlight/detail?id=1113345988","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113345988?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:19","pubTimestamp":1760534349,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1120072622","title":"Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)","url":"https://stock-news.laohu8.com/highlight/detail?id=1120072622","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120072622?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:19","pubTimestamp":1760534348,"startTime":"0","endTime":"0","summary":"Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2546114278","title":"Anteris Technologies Global Corp.6月25日成交额为48.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546114278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546114278?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:18","pubTimestamp":1750900700,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,Anteris Technologies Global Corp.成交额为48.11万美元,成交额较昨日减少54.25%,当日成交量为12.04万股。Anteris Technologies Global Corp.于2025年6月25日跌1.61%,报3.96美元,该股过去5个交易日涨5.6%,年初至今跌29.03%,过去60日涨4.21%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-25|48.11万|-54.25%|12.04万|#|2025-06-24|105.15万|40.92%|26.05万|#|2025-06-23|74.62万|-79.52%|19.41万|#|2025-06-20|364.35万|355.70%|89.05万|#|2025-06-18|79.95万|1.58%|19.73万|Anteris Technologies Global Corp是一家致力于设计、开发和商业化尖端医疗器械,以恢复健康心脏功能的结构性心脏公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626091832a71dea38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626091832a71dea38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2544940182","title":"Anteris Technologies Global Corp.6月18日成交额为79.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544940182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544940182?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:18","pubTimestamp":1750295902,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日,Anteris Technologies Global Corp.成交额为79.95万美元,成交额较昨日增加1.58%,当日成交量为19.73万股。Anteris Technologies Global Corp.于2025年6月18日涨8.27%,报4.06美元,该股过去5个交易日跌20.7%,年初至今跌27.24%,过去60日跌20.7%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-18|79.95万|1.58%|19.73万|#|2025-06-17|78.71万|-26.68%|20.59万|#|2025-06-16|107.35万|-17.71%|25.40万|#|2025-06-13|130.45万|25.10%|28.00万|#|2025-06-12|104.28万|-29.11%|21.04万|Anteris Technologies Global Corp是一家致力于设计、开发和商业化尖端医疗器械,以恢复健康心脏功能的结构性心脏公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619091832a4b188c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619091832a4b188c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2544122609","title":"Anteris Technologies Global Corp.6月17日成交额为78.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544122609","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544122609?lang=zh_cn&edition=full","pubTime":"2025-06-18 09:18","pubTimestamp":1750209501,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,Anteris Technologies Global Corp.成交额为78.71万美元,成交额较昨日减少26.68%,当日成交量为20.59万股。Anteris Technologies Global Corp.于2025年6月17日跌6.48%,报3.75美元,该股过去5个交易日跌29.91%,年初至今跌32.8%,过去60日跌27.61%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-17|78.71万|-26.68%|20.59万|#|2025-06-16|107.35万|-17.71%|25.40万|#|2025-06-13|130.45万|25.10%|28.00万|#|2025-06-12|104.28万|-29.11%|21.04万|#|2025-06-11|147.09万|-18.42%|27.50万|Anteris Technologies Global Corp是一家致力于设计、开发和商业化尖端医疗器械,以恢复健康心脏功能的结构性心脏公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618091832a4af70bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618091832a4af70bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2544987960","title":"Anteris Technologies Global Corp.6月16日成交额为107.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544987960?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:18","pubTimestamp":1750123099,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,Anteris Technologies Global Corp.成交额为107.35万美元,成交额较昨日减少17.71%,当日成交量为25.40万股。Anteris Technologies Global Corp.于2025年6月16日跌8.45%,报4.01美元,该股过去5个交易日跌25.33%,年初至今跌28.14%,过去60日跌30.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-16|107.35万|-17.71%|25.40万|#|2025-06-13|130.45万|25.10%|28.00万|#|2025-06-12|104.28万|-29.11%|21.04万|#|2025-06-11|147.09万|-18.42%|27.50万|#|2025-06-10|180.31万|71.51%|33.62万|Anteris Technologies Global Corp是一家致力于设计、开发和商业化尖端医疗器械,以恢复健康心脏功能的结构性心脏公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091831a4ad2bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091831a4ad2bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2543149651","title":"Anteris Technologies Global Corp.6月13日成交额为130.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543149651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543149651?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:18","pubTimestamp":1749863909,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日,Anteris Technologies Global Corp.成交额为130.45万美元,成交额较昨日增加25.10%,当日成交量为28.00万股。Anteris Technologies Global Corp.于2025年6月13日跌10.06%,报4.38美元,该股过去5个交易日跌7.59%,年初至今跌21.51%,过去60日跌29.47%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-13|130.45万|25.10%|28.00万|#|2025-06-12|104.28万|-29.11%|21.04万|#|2025-06-11|147.09万|-18.42%|27.50万|#|2025-06-10|180.31万|71.51%|33.62万|#|2025-06-09|105.13万|77.16%|20.31万|Anteris Technologies Global Corp是一家致力于设计、开发和商业化尖端医疗器械,以恢复健康心脏功能的结构性心脏公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091849a70888fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091849a70888fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2502870517","title":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502870517","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502870517?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:41","pubTimestamp":1736358102,"startTime":"0","endTime":"0","summary":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09014147279955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AVR"],"gpt_icon":0},{"id":"1179521583","title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1179521583","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179521583?lang=zh_cn&edition=full","pubTime":"2024-12-14 03:34","pubTimestamp":1734118456,"startTime":"0","endTime":"0","summary":"心脏瓣膜公司Anteris Technologies Global (AVR) 在纳斯达克上市首日当日暴跌12.33%,引发市场广泛关注。\nAVR当日在纳斯达克进行首次公开募股,发行价为每股6美元,共募集约8,900万美元资金。但开盘后股价即呈现大跌,盘中一度下探至5.26美元。\n市场分析认为,AVR首次公开募股增发新股导致股票供给激增,短期内形成供给压力拖累股价下跌,同时或有投机资金涌入、出货操作亦加剧了股价震荡。投资者对未来发展前景存在分歧,市场情绪转差致股价重挫。预计供需矛盾在未来将得到缓解,股价震荡将趋于平稳。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVR"],"gpt_icon":0},{"id":"2490065371","title":"澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065371","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490065371?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:45","pubTimestamp":1733816700,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,澳大利亚的人工心脏瓣膜制造商Anteris Technologies周一宣布了其 IPO 条款。该公司计划以每股6.78美元的价格发行1,480万股股票,以筹集1亿美元资金。按照拟议价格,Anteris Technologies的市值将达到2.44亿美元。该公司的股票目前在澳大利亚证券交易所上市,代码为“AVR”。Anteris是一家专注于主动脉狭窄患者的结构性心脏公司。Anteris于2024年2月14日秘密提交了申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AVR","159873"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anteristech.com","stockEarnings":[{"period":"1week","weight":0.0664},{"period":"1month","weight":0.2802},{"period":"3month","weight":-0.1059},{"period":"6month","weight":0.137},{"period":"1year","weight":-0.17},{"period":"ytd","weight":-0.1075}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。","exchange":"NASDAQ","name":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","nameEN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing),AVR,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎国际,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股价,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股市,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票价格,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票交易,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票购买,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}